News Articles Tagged: Mitochondria Targeting

Mito-LND: A Novel Approach to Mitigate Lung Tumorigenesis and Brain Metastasis

Discover how Mito-LND, a mitochondria-targeted lonidamine, is making strides in mitigating lung tumorigenesis and preventing brain metastasis, offering new hope in cancer treatment.

The Power of Precision: How Mitochondria-Targeted Lonidamine is Revolutionizing Cancer Treatment

Discover how Mito-LND, a novel mitochondria-targeted lonidamine derivative, is transforming cancer therapy by enhancing efficacy and reducing toxicity in lung cancer treatment.